But while lecanemab has been shown to slow the progression of disease in some people who receive an early diagnosis, it comes ...
Genmab to acquire Utrecht-based Merus in an all-cash deal expected to close in early 2026, adding Merus’ cancer therapies to ...
Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in ...
The human body requires protein as one of its fundamental nutritional elements, and it is known as the 'building block of the ...
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned ModelCompany AnnouncementGenmab to acquire Merus for USD 97.00 per share in an all-cash transaction ...
A team of scientists at Texas Tech University Health Sciences Center (TTUHSC) has published new evidence suggesting that the ...
A new study suggests that the blood-brain barrier (BBB) remains intact in a widely used mouse model of Alzheimer’s disease.
Rademikibart demonstrated rapid and significant improvement in lung function and asthma control in patients, with greatest improvements observed in those with elevated baseline levels of key type 2 ...
Zero-trust security mirrors biology’s best defenses. By applying least privilege, businesses can scale, stay resilient and ...
She's known as one of the most beautiful women in the world - regularly gracing the cover of Vogue and working with luxury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback